SOPHiA GENETICS (SOPH) Revenue (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Revenue data on file, last reported at $21.7 million in Q4 2025.

• For the quarter ending Q4 2025, Revenue rose 22.41% year-over-year to $21.7 million; the trailing twelve-month figure through Dec 2025 stood at $77.3 million (up 18.56% YoY), and the FY2025 full-year result was $77.3 million, up 18.56% from the prior year.
• Revenue rose to $21.7 million in Q4 2025, from $19.5 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $21.7 million in Q4 2025 to a low of $9.0 million in Q1 2021.
• A 5-year average of $14.6 million and a median of $15.4 million in 2023 frame the typical range for Revenue.
• Across the five-year window, Revenue sank 99.86% in 2021 and surged 39.96% in 2023, its largest moves.
• Tracing SOPH's Revenue over 5 years: stood at $10.9 million in 2021, then increased by 22.37% to $13.4 million in 2022, then advanced by 27.38% to $17.0 million in 2023, then increased by 4.02% to $17.7 million in 2024, then climbed by 22.41% to $21.7 million in 2025.
• Business Quant data shows SOPH's Revenue at $21.7 million in Q4 2025, $19.5 million in Q3 2025, and $18.3 million in Q2 2025.